The bioburden testing market is anticipated to grow at a CAGR of 12.3% in terms of value from 2020 to reach USD 1,611.8 Million by 2026. Bioburden testing, also known as absolute viable count testing, involves the measurement of microbial contamination on or within a product. The accumulation of bioburden can occur through raw materials used in manufacturing or introduction during the...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt